"Bleeding Time" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Duration of blood flow after skin puncture. This test is used as a measure of capillary and platelet function.
| Descriptor ID |
D001760
|
| MeSH Number(s) |
E01.370.225.625.625.100 E05.200.625.625.100 G09.188.087
|
| Concept/Terms |
Bleeding Time- Bleeding Time
- Bleeding Times
- Time, Bleeding
- Times, Bleeding
Template Bleeding Time- Template Bleeding Time
- Bleeding Time, Template
- Bleeding Times, Template
- Template Bleeding Times
- Time, Template Bleeding
- Times, Template Bleeding
Aspirin Tolerance Test- Aspirin Tolerance Test
- Aspirin Tolerance Tests
- Test, Aspirin Tolerance
- Tests, Aspirin Tolerance
- Tolerance Test, Aspirin
- Tolerance Tests, Aspirin
|
Below are MeSH descriptors whose meaning is more general than "Bleeding Time".
Below are MeSH descriptors whose meaning is more specific than "Bleeding Time".
This graph shows the total number of publications written about "Bleeding Time" by people in this website by year, and whether "Bleeding Time" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 2 | 2 |
| 2012 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bleeding Time" by people in Profiles.
-
Naik MU, Stalker TJ, Brass LF, Naik UP. JAM-A protects from thrombosis by suppressing integrin aIIbß3-dependent outside-in signaling in platelets. Blood. 2012 Apr 5; 119(14):3352-60.
-
Nielsen VG, Chawla N, Mangla D, Gomes SB, Arkebauer MR, Wasko KA, Sadacharam K, Vosseller K. Carbon monoxide-releasing molecule-2 enhances coagulation in rabbit plasma and decreases bleeding time in clopidogrel/aspirin-treated rabbits. Blood Coagul Fibrinolysis. 2011 Dec; 22(8):756-9.
-
Dallob A, Luo WL, Luk JM, Ratcliffe L, Johnson-Levonas AO, Schwartz JI, Dishy V, Kraft WK, De Hoon JN, Van Hecken A, De Lepeleire I, Radziszewski W, Wagner JA, Lai E. The effects of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin. Platelets. 2011; 22(7):495-503.
-
Lai E, Schwartz JI, Dallob A, Jumes P, Liu F, Kraft WK, Royalty J, Chodakewitz JA, McCrary Sisk C, Radziszewski W, Wagner JA. Effects of extended release niacin/laropiprant, laropiprant, extended release niacin and placebo on platelet aggregation and bleeding time in healthy subjects. Platelets. 2010; 21(3):191-8.
-
Matuskova J, Chauhan AK, Cambien B, Astrof S, Dole VS, Piffath CL, Hynes RO, Wagner DD. Decreased plasma fibronectin leads to delayed thrombus growth in injured arterioles. Arterioscler Thromb Vasc Biol. 2006 Jun; 26(6):1391-6.
-
Alugupalli KR, Michelson AD, Joris I, Schwan TG, Hodivala-Dilke K, Hynes RO, Leong JM. Spirochete-platelet attachment and thrombocytopenia in murine relapsing fever borreliosis. Blood. 2003 Oct 15; 102(8):2843-50.